Collin Hill

Collin Hill is an experienced professional in the field of metabolomics and mass spectrometry, currently serving as a Scientific Partner in Emerging Neonatal Screening at Revvity since May 2023. Previously, Collin held various roles at PerkinElmer, Inc., including Senior Product Specialist and Global Applications Manager. Before that, Collin worked as a Metabolomics Scientist I at BERG Health and gained foundational experience in metabolomics at Agios Pharmaceuticals and Pfizer. Collin's educational background includes an MBA from the University of Massachusetts Amherst, an MS in Pharmaceutical Science with a focus on Pharmacology from Northeastern University, and a BS in Biochemistry & Molecular Biology from the University of Massachusetts Amherst.